In parallel to the cell viability results in murine 4T1 cell line, treatment with gene therapeutics (BRCA1 + NP and BRCA2 + NP) in syngeneic mouse model carrying 4T1-induced breast tumors, showed significant tumor regression pattern in comparison to the NP control group. This evidence concerns the gene BRCA2 and breast neoplasm.